OCT 03, 2017
Recent findings have suggested that injections of bevacizumab may introduce silicone oil droplets into the vitreous cavity. In this 1-Minute Video, Dr. David Lally performs a vitrectomy on a patient who presented with floaters and decreased vision a day after receiving a bevacizumab injection for wet AMD. Numerous silicone oil bubbles were detected in his vitreous cavity. Because his condition did not improve after 1 month of observation, a 25-gauge pars plana vitrectomy was performed to remove the silicone oil.
Relevant Financial Disclosures: None